BARCELONA, July 12, 2012 /PRNewswire/ --
This site is part of the http://www.esteve.com corporate web portal
ESTEVE announces the launch of a new website (http://www.esteve.es/EsteveFront/IDI.do?lng=en) with the purpose of communicating the Company's R&D and the innovative models of collaboration currently implemented. Newly formatted and fully integrated in the http://www.esteve.com web portal, this site reinforces the commitment of ESTEVE to R&D with emphasis on a solid strategy to provide new therapeutic solutions for unmet medical needs in highly prevalent diseases of high social impact.
With its primary focus in analgesia, ESTEVE is developing innovative therapies for pain. Two projects are presently undergoing clinical development for the treatment of neuropathic pain and moderate to severe acute and chronic pain.
One of these projects involves S1RA, a highly selective Sigma-1 Receptor Antagonist that offers a new approach and a new mechanism of action in a field (neuropathic pain) strongly in need of novel, more effective and safer therapies.
The new website also describes the innovative partnering strategy in R&D as well as ESTEVE's network of excellence built through unique collaborative models. This network includes different types of alliances, from public-private partnerships -such as the HIVACAT program to develop an effective vaccine against HIV and the Sanfilippo project to develop a treatment for a rare childhood disease- to R&D consortiums such as Neogenius for pain research.
One of the key features of this site is its attractively designed interface for portfolio presentation, which includes the various ongoing R&D programs, i.e. in-house projects in analgesia, projects in collaboration with other centers or companies, and in-licensed projects.
With language and information customized for each audience, this new website provides specific information for scientists, healthcare providers, industry partners, patients and other stakeholders.
ESTEVE is a leading chemical-pharmaceutical group in Spain and has a strong international presence. Ever since its foundation in 1929, ESTEVE has been firmly committed to excellence and has been using its best efforts to promote health and improve people's quality of life.
Copyright©2012 PR Newswire.
All rights reserved